Sustainability & Climate

Thanks to a major philanthropic gift, the Jardin botanique launches 'A Haven for Birds,' a new initiative to protect urban wildlife and engage the public.

With a 36% viewership surge for its All-Star Match, Major League Volleyball proves it's a major contender, riding a wave of strategic growth and national interest.

For a second year, ABA Centers ranks among the Americas' fastest-growing firms, tackling the autism care crisis with a disruptive, no-waitlist model.

Family-owned Canalta Hotels is upgrading two Alberta properties, blending modern amenities with a unique loyalty program that plants trees for every stay.

With its 10th clinic opening in Greenwich Village, Ever/Body and its backer AMP are scaling a new model for beauty, driven by consumer demand and big money.

ASU's business school honors Todd LaPorte for transforming HonorHealth, expanding patient access, and driving healthcare innovation across Arizona.

A $10M investment from BVF Partners propels Entera Bio’s revolutionary oral osteoporosis drug into a pivotal Phase 3 trial, a major step for patients.

Khloé Kardashian's Khloud brand expands with new Protein Chips, leveraging celebrity power and a strategic Target partnership to disrupt the snack market.

The sober curious movement gets a boost as NOOT's nootropic-infused cocktails land in Sprouts stores, offering a social buzz without the booze.

As teen HPV vaccination rates stagnate, a new national campaign urges families to fight online falsehoods by turning to their most trusted source: their doctor.

Jeep owners can now get premium Alpine sound systems directly from dealerships, a strategic move reshaping the aftermarket landscape for OEMs and suppliers.

Dr. Amit Singal, a leading hepatologist, joins Curve Biosciences as CMO, aiming to leverage AI to find chronic liver disease before it becomes incurable.

IFF targets the booming pet wellness market with PureStrong™, a probiotic built from canine science. Is this the future of dog digestive health?

March job data reveals a complex picture. While modest gains were made, a hiring slowdown and wage stagnation signal a new, cooler phase for the US economy.

With promising clinical data, Clarametyx promotes key executives to accelerate its novel attack on chronic respiratory disease biofilms. Jennifer Anderson reports.

The gold miner reported a massive profit jump, but a closer look reveals non-cash gains, soaring costs, and a high-stakes strategy in Zimbabwe.

With FDA clearance for clinical trials, CanWell Pharma’s novel CAN016 ADC brings a two-pronged attack against drug-resistant HER2-positive cancers.

The full commercial launch of the Aeros Modular Stem System brings advanced 3D printing and a novel surgical approach to the competitive ankle replacement market.

Tired of ineffective hair gummies? A new biotech firm backed by Khosla Ventures claims its 'pill-strength' gummy delivers real results in 30 days.

After an AI agent lost a fortune misreading a sarcastic post, Claw Wallet launches to build digital fortresses for the booming, but vulnerable, on-chain AI economy.